Abstract DsbA proteins, the primary catalysts of protein disulfide bond formation, are known to affect virulence and penicillin resistance in Gram-negative bacteria. We identified a putative DsbA homologue in the Grampositive pathogen Staphylococcus aureus that was able to restore the motility phenotype of an Escherichia coli dsbA mutant and thus demonstrated a functional thiol oxidoreductase activity. The staphylococcal DsbA (SaDsbA) had a strong oxidative redox potential of À131 mV. The persistence of the protein throughout the growth cycle despite its predominant transcription during exponential growth phase suggested a rather long half-life for the SaDsbA. SaDsbA was found to be a membrane localised lipoprotein, supporting a role in disulfide bond formation. But so far, neither in vitro nor in vivo phenotype could be identified in a staphylococcal dsbA mutant, leaving its physiological role unknown. The inability of SaDsbA to interact with the E. coli DsbB and the lack of an apparent staphylococcal DsbB homologue suggest an alternative re-oxidation pathway for the SaDsbA.
Introduction
Disulfide bonds between cysteine residues support the correct folding of proteins and maintain their structural integrity and activity. Disulfide bond containing proteins are usually localised in extracytoplasmic compartments or secreted into the medium, but are rare in the reducing environment of the cytoplasm. Although disulfide formation can occur spontaneously under oxidising conditions, this reaction is unspecific and slow (Anfinsen 1973) . In vivo, enzymatic systems ensure efficient and correct disulfide bond formation. The primary catalyst of this reaction in Escherichia coli is the extensively studied periplasmic thiol-disulfide oxidoreductase DsbA. It is a monomeric 21-kDa protein containing a redox active C-X-X-C sequence embedded in a thioredoxin fold, typical for the proteins of this family (reviewed in Kadokura et al. 2003) . Upon catalysing disulfide bond formation, the two cysteines of DsbA become reduced and are subsequently re-oxidised by the inner membrane protein DsbB, which passes the electrons to the electron transfer chain via quinone reduction (Guilhot et al. 1995; Kishigami et al. 1995; Kishigami and Ito 1996; Bader et al. 1998 Bader et al. , 1999 .
Escherichia coli dsbA mutants have a pleiotropic phenotype and, amongst others, lack motility due to the improper assembly of the flagellar motor (Jones et al. 1990; Dailey and Berg 1993) . Interestingly, dsbA mutants of several Gram-negative pathogenic bacteria also exhibit a reduced virulence, due to the absence of critical disulfide bonds in exotoxins, adherence factors or pili (Yu and Kroll 1999; Yu et al. 2001; Stenson and Weiss 2002; Ha et al. 2003; Burall et al. 2004; Miki et al. 2004) . So far, an involvement of a DsbA homologue in virulence of a Gram-positive pathogen has not been documented.
In Gram-negative bacteria, disulfide bond formation occurs in the periplasm. Gram-positive bacteria do not possess a classic periplasmic compartment, and very little is known about disulfide bond formation in these organisms. The Bacillus brevis Bdb was the first DsbA homologue of a Gram-positive bacterium shown to have thiol oxidase activity by complementing the motility of an E. coli dsbA mutant (Ishihara et al. 1995) . Subsequently, the Bacillus subtilis BdbC and BdbD were demonstrated to be functional homologues of the E. coli DsbA and DsbB, respectively, and to be involved in the development of competence (Erlendsson and Hederstedt 2002; Meima et al. 2002) . Although some of the secreted virulence factors produced by the human pathogen Staphylococcus aureus, such as all staphylococcal enterotoxins and the beta-haemolysin, are known to contain disulfide bonds in their active forms (Hovde et al. Dziewanowska et al. 1996) , the mechanism by which these disulfide bonds are formed has never been examined. In this study we describe the identification and functional characterisation of a putative DsbA homologue (SA2197) in S. aureus and analyse its importance for virulence and antibiotic resistance.
Materials and Methods
Bacterial strains, plasmids, and media
The strains and plasmids used in this study are listed in Table 1 . The cells were grown at 37°C in Luria-Bertani (LB) medium. When required, tetracycline 10 lg/ml, or ampicillin 100 lg/ml were added.
DNA manipulations
Preparation of chromosomal and plasmid DNA, PCR, and Southern blot analysis were performed by standard procedures (Sambrook et al. 1989) . Probes were labelled with the PCR DIG Probe Synthesis Kit (Roche, Rotkreuz, CH, USA), following the manufacturer's instructions. Transductions were done with phage 80a as described previously (Berger-Ba¨chi 1983) . Primers used for PCR, sequencing and primer extension reactions are listed in Table 2 . Isolation and analysis of total RNA Total RNA was isolated according to the protocol of Cheung (Cheung et al. 1994) , using the FastRNA kit (BIO 101, Vista, CA, USA). Northern blot analysis was performed as described by Sambrook (Sambrook et al. 1989) . The transcriptional start was determined by primer extension using the 32 P-labeled primers PEX1, PEX2 and PEX3 as described by Rossi (2003) .
dsbA promoter-reporter gene construct A 1 kb DNA fragment covering the SA2198-dsbA promoter region (dsbAp) of S. aureus was amplified using the primers DsbApf and DsbApr, digested with KpnI and NcoI and cloned in front of the luciferase gene of plasmid pSP-luc+. A 2.6 kb KpnI-EcoRI fragment, including the dsbA promoter region fused to the luciferase coding region was subsequently subcloned into suicide plasmid pBT ) yielding plasmid pBT dsbAp::luc+, which was electroporated into RN4220. A co-integrate was selected and used as a donor to transduce strain BB270, resulting in strain MB261. The luciferase activity was measured as described earlier . SaDsbA-isolation and antibody preparation
The primers SaDsbAf and SaDsbAr were used to amplify a fragment encoding the presumed mature part of SaDsbA lacking its signal sequence (mSaDsbA). The fragment was cloned into pET11a using NheI and BamHI restriction sites. The cloning procedure did add four supplementary amino acids M-A-S-M to the N-terminus of mSaDsbA, thereby introducing a new start methionine to the mSaDsbA. The resulting plasmid pmSaDsbA was transformed into Rosetta DE3 cells (Novagen) for overexpression. Cells were grown in LB medium to an OD 600 of 0.8 and induced with 1 mM IPTG. After 3 h, cells were collected by centrifugation and resuspended in 20 mM Tris/HCl pH 8.0. The cells were disrupted (Cell Cracker, EMBL, Heidelberg Germany), and the debris separated by centrifugation for 30 min at 15,000 g. The supernatant was applied onto a QA-52 anion-exchange column (Whatman, Brentfort, UK) pre-equilibrated with 20 mM Tris/HCl pH 8.0. Proteins were eluted with a 0-1 M gradient of NaCl in 20 mM Tris/HCl pH 8.0. Fractions containing mSaDsbA were pooled, dialysed against 20 mM HEPES/NaOH pH 8.0 and applied onto a SE52 cation-exchange column (Whatman). mSaDsbA was eluted with a gradient of 0-1 M NaCl in 20 mM HEPES/ NaOH pH 8.0. One milligram of the eluted, homogenous mSaDsbA was used to raise chicken antibodies (DAVIDS Biotechnologie, Regensburg, Germany).
Fluorescence spectroscopy and determination of the redox potential
The redox potential of mSaDsbA was determined essentially as previously described (Grauschopf et al. 2003) by measuring the redox equilibrium of mSaDsbA with glutathione using a specific fluorescence intensity change at 327 nm between the oxidised and reduced state of the protein.
Localisation of SaDsbA
Exponentially growing Newman cells harvested at OD 600 2 were disrupted and fractionated into supernatant, cell wall, cell membrane and cytoplasm, according to Schneewind (1993) . Protein fractions corresponding to a 1-ml culture were subjected to Western analysis using antigen-purified anti-DsbA antibodies at a dilution of 1:5,000. To demonstrate the lipoprotein nature of SaDsbA, growing cells were challenged with 50 lg/ml globomycin (Sankyo Corp., Tokyo, Japan) at OD 600 0.4 and harvested at OD 600 2. Aliquots containing 15 lg whole protein were subjected to Western blot analysis using the conditions given above.
Complementation of an E. coli dsbA mutant by the dsbA gene of S. aureus A 1.4-kb fragment covering the SA2198-dsbA operon as well as the SA2198-dsbA promoter was amplified using the primers Pr1f and Pr1r. The obtained insert was cloned into the EcoRV site of pBR322, yielding pAD2. Plasmid pAD11, carrying a translational in-frame fusion of the E. coli OmpA signal peptide, MKKTAIAIAVA-LAGFATVAQA, with the putative mature part of was constructed by amplifying a 735-bp fragment encoding an SaDsbA lacking its 18 Nterminal amino acids with the primers Pr3f and Pr3r, and cloning it into the StuI-EcoRI restricted pEC52 (Fabianek et al. 1998) . In this construct the codons for cysteine 19 and glycine 20 were changed to codons for alanine and serine, respectively, thereby eliminating the signal peptidase II recognition site of SaDsbA.
To determine the complementation of the non-motile E. coli dsbA mutant strain JBC571 (Bardwell et al. 1991) , plasmids pAD2, pAD11 as well as the empty vectors pBR322 and pISC2 were electroporated into E. coli JCB571. The motility of the resulting strains AD13, AD28, AD15 and AD29, respectively, was tested by placing filter discs of 6 mm diameter (bioMe´rieux) soaked in the respective overnight cultures, onto an LB plate containing 0.3% agar and 0.2% arabinose and incubating for 12.5 h at 37°C. To test the dependence of the complementation on the presence of DsbB, plasmids pAD2, pAD11, pBR322 and pISC2 were electroporated into the E. coli dsbA dsbB double mutant JCB818, yielding strains AD59, AD60, AD189 and AD190, respectively. As a control, pBR322 was electroporated into the wild-type strain JCB570, yielding AD191. The dependence of the complementation of the dsbA and dsbA dsbB mutants on the presence of cystine was demonstrated by growing the strains overnight in liquid M9 medium containing 4 lg/ml of each amino acids except cysteine, 0.4% glycerol and 100 lg/ml ampicillin. Thirty microlitre of the overnight culture, resuspended to an OD 600 of 0.2, were placed on 6 mm filter discs which were transferred to an M9 agar plate containing 0.3% agar, 0.2% arabinose and 4 lg/ml of each amino acid except cysteine. When required, 25 lg/ml cystine was added to the medium. The distance reached by motile swarming cells was determined after overnight incubation.
Insertional inactivation of dsbA
The dsbA gene from S. aureus was inactivated by replacing a 249 bp internal fragment with a 1.6-kb tetL cassette. An 845-bp fragment upstream of dsbA was amplified using pAD2 as a template and the primers Pr4f and Pr4r, digested with EcoRI, and inserted into the 4.7-kb fragment EcoRI-HpaI fragment of pAD2. The three bases GTT at the 3'-end of the insert restored an HpaI site after ligation with the vector. The 1.6-kb tetL fragment was amplified by PCR from plasmid pBT using the primers TetL+ and TetL-and inserted into the restored HpaI site. From this product the 2.7-kb EcoRI-BamHI fragment was excised and inserted into the corresponding sites of pEC4, yielding plasmid pAD7. Tetracycline resistant clones obtained after electroporation of pAD7 into the S. aureus RN4220 were screened for loss of erythromycin resistance. About 5% of the tetracycline resistant clones were sensitive to erythromycin, indicating loss of the plasmid backbone due to a double crossover. The dsbA::tetL allele of the resulting strain AD19 was transferred to strains BB270, Newman, MSSA112, and 8325-4 by phage transduction, resulting in strains AD21, AD22, AD23, and AD188 respectively. The deletion of the dsbA fragment on the chromosome was confirmed by Southern blot analysis.
Characterisation of the S. aureus dsbA mutant Susceptibility to dithiothreitol (DTT) was tested by placing sterile filter discs of 6 mm diameter impregnated with 20 ll of a 1 M DTT on a lawn of cells diluted to McFarland 0.5 in 0.8% NaCl and spread on Mu¨ller-Hinton plates. The inhibition zone was measured after overnight incubation at 37°C. Susceptibility to antibiotics was assessed by E-test (AB Biodisk, Solna, Sweden) following the recommendations of the manufacturer. The relative resistance to oxacillin of the strain pair BB270/AD21 was compared on plates containing a gradient of oxacillin from 0 to 200 lg/ml.
Measurement of the haemolytic activity
The haemolytic activities of strain 8325-4 and its dsbA defective derivative AD188 were essentially determined following the protocol of Nilsson and co-workers (Nilsson et al. 1997) . After incubation of the washed erythrocytes with diluted culture supernatant, the samples were centrifuged for 1 min at 7000 g. The optical density at 415 nm due to the released haemoglobin was measured and plotted against the dilution factor of the culture supernatant.
Animal models
Strain Newman and its dsbA mutant AD22 were used in two pathogenicity assays. The Caenorhabditis elegans killing assay was performed according to the protocol by Sifri and co-workers (Sifri et al. 2003) . In the mouse model for septic arthritis, the protocol described by Bremell and co-workers (Bremell et al. 1991) was followed, using 15 mice and a bacterial load of 6·10 6 cells.
Results
Identification of a putative DsbA homologue B. subtilis BdbD was previously identified as a close E. coli DsbA homologue in a Gram-positive organism (Fabianek et al. 2000) . A BLAST search for Bdb homologues in the S. aureus NCTC8325 genome database resulted in the identification of a 199-amino acid ORF with 41% similarity to BdbD that was tentatively termed SaDsbA. No further Dsb or Bdb homologues were found in any of the published genome sequences of S. aureus. Direct chromosomal sequencing of the NCTC8325 derivative BB270 over the region covering dsbA showed an exact match with the corresponding published genome sequences of NCTC8325 and COL. In S. aureus MW2, Mu50, N315, MRSA252 and MSSA476, a G to A transition causes the valine residue at position 38 to be changed to a isoleucine. In addition, a G to T transversion causes the change of leucine at position 52 to a phenylalanine in strain MRSA252. The deduced sequence of the 20 N-terminal amino acids of the S. aureus DsbA revealed the characteristics of a lipoprotein signal sequence with an ILTACG predicted signal peptidase II cleavage site (PROSITE motive PS00013) (Tjalsma et al. 2000; Sutcliffe and Harrington 2002) , suggesting SaDsbA to be an extracytoplasmic lipoprotein with a lipid attachment site at cysteine 19.
The predicted size of 181 aa of the deduced mature SaDsbA was similar to that of DsbA from other bacteria, and conserved residues were found over the entire length of its primary structure (Fig. 1) . SaDsbA harbours, with its C-P-Y-C motif, the C-X-X-C active site characteristic for thiol-disulfide oxidoreductases, and possesses a proline residue at position 154, which aligns well with the cis-proline at position 151 of E. coli DsbA (Fig. 1) . The cis-proline, strongly conserved in all members of the thioredoxin family, and positioned close to the C-X-X-C motif in their native form (Martin 1995) , has a critical role in the resolution of the mixed disulfide intermediate (Kadokura et al. 2004 ) and affects the stability of DsbA proteins (Charbonnier et al. 1999) .
Upstream of the S. aureus dsbA, and separated by 21 nucleotides, a 360-bp open reading frame (ORF), SA2198, was identified. This ORF encodes a putative protein of 120 amino acids that shares no apparent similarity to any other protein with known function. SA2198 appears to have a lipoprotein signal sequence with a FISGCG predicted signal peptidase II cleavage site. The sequence of this ORF was found to be identical in all the published S. aureus genome sequences, suggesting that its gene product is functional in S. aureus. Additionally, a similar genetic organisation was found in the closely related Staphylococcus epidermidis, with the two predicted lipoproteins, SE1987 sharing 68% sequence similarity with SaDsbA, and SE1988 sharing 65% similarity with SA2198.
Analysis of the dsbA transcript
Northern blot analyses with probes covering either dsbA or SA2198-dsbA, yielded a single 1.3-kb transcript (Fig. 2a) , indicating that SA2198 and dsbA are cotranscribed, thereby forming a bi-cistronic operon. The level of the 1.3-kb transcript was high during early exponential growth (30 min to 2 h) and strongly decreased thereafter (3 and 5 h). A dsbA promoter-luciferase reporter gene fusion, co-integrated into the S. aureus chromosome of strain MB261, confirmed the growth phase-dependent expression pattern of SA2198-dsbA (Fig. 2b) . Western blot analysis, however, demonstrated SaDsbA to be present at all time points analysed, irrespective of the transcription pattern of its gene (Fig. 2c) .
Primer extension experiments, using primers binding either within dsbA or SA2198 coding sequences, yielded one transcriptional start point 42 bp upstream of SA2198 (Fig. 3) , confirming the co-expression of these two genes. The identified transcriptional start point is preceded by a sequence (TTGTAGÀ 20 -TATAGT), which is fairly well resembling the consensus promoter sequence of the house-keeping r A factor (TTGACAÀ 16-18 -TATAAT) (Helmann 1995; Rao et al. 1995) , with the predicted À35 and À10 regions being separated, however, by an unusually long spacer region of 20 nucleotides.
Production of SaDsbA in E. coli and determination of its redox potential
We produced the predicted mature part of SaDsbA in the cytoplasm of E. coli strain AD44 containing plasmid pmSaDsbA. After the two-step purification using an anion-exchange and a cation-exchange column, 80 mg of pure mSaDsbA were obtained from an original 6 l culture. We found that oxidised mSaDsbA, similarly to its E. coli homologue exhibited an increase in tryptophane fluorescence at 327 nm upon reduction of the disulfide bond by dithiothreitol. We made use of this redox-state-dependent fluorescence to determine the intrinsic redox potential of mSaDsbA. By equilibrating the protein with different glutathione redox buffers, a A Northern blot analyses of dsbA expression in strain BB270 using a DIG-labelled DNA-probe specific for SA2198 and dsbA. B The transcriptional activity of the dsbA promoter was determined by measuring the luciferase activity of a dsbA::luc+ fusion (open symbols). Bacterial growth was measured as the OD 600 (solid symbols). C Detection of SaDsbA by Western blot analysis. Fifteen micrograms obtained from whole-cell extracts were loaded in each lane Fig. 1 Alignment of the conserved active site and of the cis-proline region of some members of the DsbA protein family. The alignment was performed with the program ClustalW (Thompson et al. 1994 ) using the default parameters. Identical residues are underlayed in black. Dark grey and grey shaded residues correspond to conserved and semi-conserved substitutions, respectively.
1 The position indicated refers to the first aa in the alignment of the mature protein. The position of the cleavage site was predicted by the program SignalP using the standard parameters (Bendtsen et al. 2004 ).
2 The indicated length refers to the mature protein. Sequences shown are from S. aureus, S. epidermidis, B. subtilis, Bacillus anthracis, Neisseria meningitidis, E. coli, Salmonella typhimurium, Yersinia pestis, Haemophilus influenzae, Vibrio cholerae and Pseudomonas aeruginosa single transition with an equilibrium constant (K eq ) of 2.09±0.27·10
À4 M was detected, corresponding to a redox potential (E' o ) of À131 mV (Fig. 4) . Thiol-disulfide oxidoreductases of the thioredoxin family have redox potentials ranging from À270 mV for the E. coli thioredoxin to À122 mV for the most oxidative of all, the E. coli DsbA.
Localisation of SaDsbA
To confirm that SaDsbA is a lipoprotein, cells of strain Newman were fractionated into cell wall, cell membrane and cytoplasm. The fractions were subjected to Western blot analysis using polyclonal antibodies raised against the purified SaDsbA. An antigen corresponding to the expected size of 21.0 kDa was detected exclusively in the membrane fraction (Fig. 5) . Additionally, no SaDsbA was detected among TCA precipitated proteins obtained from the culture supernatant. In order to confirm the lipoprotein character of SaDsbA, we challenged exponentially growing cells of strain Newman with globomycin, an antibiotic which inhibits the cleavage of the lipoprotein signal sequence by blocking signal peptidase II, resulting in the accumulation of an unprocessed form of the protein that typically runs 2-3 kDa higher than the mature lipoprotein (Inukai et al. 1984 ). This specific effect of globomycin has been previously used for analysis of lipoprotein maturation in S. aureus (Navarre et al. 1996) . Protein extracts from cells treated with globomycin contained a second band running at a slightly higher molecular weight, as expected for the unprocessed SaDsbA (Fig. 6) .
Complementation of an E coli dsbA mutant E. coli dsbA mutants are impaired in motility due to their inability to form the disulfide-bond of the flagellar protein FlgI (Jones et al. 1990; Dailey and Berg 1993) . This phenotype has been used to identify genes Fig. 5 Subcellular localisation of SaDsbA. Cells of strain Newman were fractionated in cell wall (cw), cell membrane (mem) and cytoplasmic (cyto) fractions. As control, 30 ng of purified mature staphylococcal DsbA (mSaDsbA) was loaded. The protein fractions were separated on a 12% SDS-PA gel and analysed by Western blotting using the anti-DsbA antibody. The amount of protein of each fraction corresponded to a 1-ml culture Fig. 4 Redox equilibrium of SaDsbA with glutathione. SaDsbA was incubated in the presence of 1 mM GSSG and varying concentrations of GSH in 100 mM sodium phosphate, pH 7.0 at 25°C. The tryptophane fluorescence at 327 nm was recorded, and data were fitted as described (Grauschopf et al. 2003 ) Fig. 3 Determination of the transcription start site of the SA2198 -dsbA transcript by primer extension. The signal detected using the cÀ 32 P labelled primer PEX3 is designated by an arrow. The same start site was obtained with the primers PEX1 and PEX2 (data not shown). The portion of the sequence represented in the picture is written in italics. The À10 region, the mapped transcriptional start, the ribosome binding site and the first amino acids of SA2198 are indicated that complement dsbA mutants (Ishihara et al. 1995; Ng et al. 1997) . To demonstrate the functionality of SaDsbA, we complemented the E. coli dsbA mutant strain JCB571 with plasmid pAD2, containing SA2198 -dsbA. This construct clearly restored the motility of the dsbA mutant, although not to wild-type levels, whereas complementation with the empty plasmid pBR322, had no effect on motility of the mutant (Fig. 7) . To exclude that the efficiency of complementation was impaired because of incompatibilities of the staphylococcal gene at the transcriptional or export level in E. coli, we complemented JCB571 with plasmid pAD11, harbouring a sequence encoding a chimeric protein where the signal sequence of the E. coli outer membrane protein OmpA was fused to the predicted mature part of SaDsbA. Complementation of the dsbA mutant with pAD11 restored the motility of JBC571 in a way that was almost identical to that obtained with pAD2 (Fig. 7) . In order to assess whether the activity of SaDsbA in the E. coli mutant was dependent on the presence of E. coli DsbB, the motility of an E. coli dsbA dsbB double mutant was tested in a similar way. Since it is known that cystine, a di-amino acid resulting from the oxidation of cysteine, can functionally complement a dsbB mutant (Dailey and Berg 1993) , the motility tests were performed on an M9-based swarm agar devoid of cysteine. On this medium, none of the plasmids encoding the S. aureus DsbA were able to complement either the dsbA dsbB double mutant (Fig. 8) , or the dsbA single mutant (not shown). When the swarm agar was supplemented with 25 lM cystine, the strains containing pAD2 or pAD11 partially restored motility of both the single and the double mutant (Fig. 8) .
Inactivation of dsbA in S. aureus
In order to analyse the function of dsbA in S. aureus, a dsbA mutant was constructed by replacing an internal 249-bp dsbA fragment with a tetL resistance cassette. The dsbA deficient strains were not impaired in aerobic growth. Since dsbA mutants of E. coli have been shown to have an increased sensitivity to reduced dithiothreitol (DTT) (Missiakas et al. 1993) , we tested the S. aureus mutant strains for growth inhibition by this substance. The sensitivities of strains AD21, AD22 and AD23 to this substance were the same as those of the respective wild types (data not shown). Another reported phenotype of E. coli dsbA is a reduced resistance to the b-lactam antibiotic benzylpenicillin (Missiakas et al. 1993) . Since many proteins of S. aureus involved in resistance to antibiotics contain cysteine residues that might form disulfide bonds, we tested the resistance of the S. aureus mutants to various antibiotics using E test or antibiotic gradient plates. The tested antibiotics belonged to various classes, targeting cell wall biosynthesis (beta-lactams and glycopeptides), protein synthesis (aminoglycosides, lincosamides, macrolides), DNA gyrase activity (fluorochinolones) or RNA synthesis (rifampicin). However, no significant difference could be seen between wild-type and dsbA mutant strains with respect to the resistance levels of all antibiotics analysed (data not shown).
The S. aureus beta-haemolysin, also termed sphingomyelinase C, requires a disulfide bond for activity Fig. 7 Complementation of the motility of an E. coli dsbA mutant. Partial restoration of the E. coli dsbA deficient strain JCB571 by the staphylococcal DsbA, alone (pAD11) and in combination with SA2198 (pAD2) Fig. 6 Influence of globomycin on the maturation of DsbA. Bacterial cultures were treated with 0 or 50 lg/ml globomycin, respectively. Fifteen micrograms of proteins from whole-cell extracts were analysed by Western blotting using the anti-DsbA antibody. As control, 30 ng of the purified (mSaDsbA) was loaded (Dziewanowska et al. 1996) . We therefore compared the appearances and diameters of the beta-haemolysis-zones of the dsbA defective strains AD19, AD21, AD22 and AD23 and their respective parental strains RN4220, BB270, Newman and MSSA1112 on sheep blood agar plates, but were unable to observe notable differences. Similarly, no significant differences were found in the release of haemoglobin from sheep blood cells challenged with supernatants from stationary phase cultures of the beta-haemolysin producing strain 8325-4 or its corresponding dsbA mutant AD188 (data not shown).
To assess the impact of DsbA on virulence, strain Newman and its dsbA defective derivative AD22 were tested in a Caenorhabditis elegans killing assay (Sifri et al. 2003) . There was no significant difference between wild type and mutant strain, neither with respect to killing rate, nor killing kinetics (C.D. Sifri, unpublished results) . The same strains were also tested in a mouse model for septic arthritis (Bremell et al. 1991) . The severity of arthritis, weight decrease and mortality were monitored over a period of 13 days, but no notable difference was observed between Newman and AD22 (I.M. Jonsson, unpublished results).
Discussion
The family of DsbA proteins is known to constitute the primary catalyst of protein disulfide bond formation in Gram-negative bacteria (reviewed in Kadokura et al. 2003) . Members of the DsbA family have been associated in Gram-negatives with pathogenicity and penicillin resistance (Missiakas et al. 1993; Yu and Kroll 1999) . With the exception of the Bdb proteins of the genus Bacillus (Ishihara et al. 1995; Bolhuis et al. 1999; Erlendsson and Hederstedt 2002) , nothing is known about how disulfide bond formation is accomplished by Grampositives. We have identified a potential DsbA homologue in the human pathogen S. aureus. This is of particular interest, since the active forms of various staphylococcal virulence factors, such as enterotoxins and beta-haemolysin, require disulfide bond formation (Hovde et al. 1994; Dziewanowska et al. 1996) . The localisation of SaDsbA as a membrane-anchored lipoprotein supports a putative role in disulfide bond formation of excreted virulence factors.
Heterologous complementation of an E. coli dsbA mutant demonstrated that SaDsbA had in fact a functional thiol-disulfide oxidoreductase activity. Moreover, the measured redox potential of SaDsbA was very similar to that of E. coli DsbA, indicating that the purified staphylococcal protein is strongly oxidative. However, the apparent lack of a phenotype, either in vitro or in animal infection models, leaves the role of SaDsbA in S. aureus open.
Despite its predominant transcription during exponential growth, Western blot analysis demonstrated the presence of SaDsbA throughout the growth. This indicated that SaDsbA showed a rather long half-life and that it might interact with surface associated, as well as excreted proteins, which are predominantly produced by S. aureus during the exponential and stationary growth phases, respectively. The anchoring of SaDsbA to the membrane is unusual for the oxidative members of the DsbA family, which are generally secreted through the Sec pathway and cleaved by signal peptidase I, resulting in soluble periplasmic proteins (Schierle et al. 2003) . However, recently Tinsley and co-workers reported that two of the three DsbA homologues produced by the Gram-negative pathogen Neisseria meningitidis are associated with the inner membrane via a lipoprotein anchor (Tinsley et al. 2004) . The particularity of neisseria to secrete toxin-filled outer-membrane vesicles (Pettit and Judd 1992) was postulated to lead to the loss of periplasmic enzymes, in particular the non-membrane-associated DsbA homologue (Tinsley et al. 2004 ). Gram-positive bacteria, missing an outer-membrane, have to prevent the diffusion of critical enzymes. A thick, almost impermeable cell wall defining a pseudoperiplasm, as in B. subtilis, could compensate for the lack of it (Merchante et al. 1995) . B. brevis, whose DsbA homologue Bdb is predicted to have a cleavable signal sequence (Ishihara et al. 1995) , probably makes use of this diffusion barrier. An alternative strategy to prevent diffusion of secreted proteins is anchoring them to the membrane via a lipoprotein anchor or a transmembrane anchor, as postulated for BdbD of B. subtilis (Erlendsson and Hederstedt 2002). Lipoproteins of Gram-positive bacteria have been proposed to constitute the functional equivalent of Gram-negative periplasmic proteins (Nielsen and Lampen 1982) , which may be the case for SaDsbA.
In E. coli, re-oxidation of DsbA is achieved by the action of DsbB (Guilhot et al. 1995; Kishigami et al. 1995; Kishigami and Ito 1996) , and in B. subtilis, BdbD is re-oxidised by BdbC (Erlendsson and Hederstedt 2002) .
The experimental results of the present study strongly suggest that the E. coli DsbB was not able to re-oxidise SaDsbA. However, further biochemical experiments would be required to definitely confirm the lack of Fig. 8 Complementation of the motility of an E. coli dsbA dsbB double mutant. Where indicated (+Cys), cystine was added at a concentration of 25 lg/ml interaction between those two proteins. The absence of any DsbB or BdbC homologue, however, indicates that the re-oxidation of the staphylococcus DsbA may be carried out differently. A BLAST search through all sequenced bacterial genomes revealed that a large majority of species encoding a DsbA/BdbD homologue also harbour a DsbB/BdbC homologue. Notable exceptions besides S. aureus and S. epidermidis were the insect symbionts Buchnera aphidicola and Wigglesworthia glossinidia. Both organisms feature very small genomes (616 respectively 697 kb) that resulted from reductive genome evolution as a consequence of their endosymbiotic life forms (Akman et al. 2002; van Ham et al. 2003) . Neither function nor activity of DsbA in these organisms are established, but the fact that the gene has been conserved while hundreds of others were discarded by the evolution speaks for its importance. Additionally, it suggests that some bacteria may use a different way to re-oxidise DsbA. The di-amino acid cystine for instance was shown to relieve the phenotype of an E. coli mutant lacking dsbB at concentrations as low as 20.8 lM (Dailey and Berg 1993) . Interestingly, cystine is present at a concentration of 40 lM in human plasma (Chawla et al. 1984; Jones et al. 2000) . Since S. aureus is a human pathogen and is therefore often in contact with blood plasma, cystine might contribute to the re-oxidation of SaDsbA under such conditions. Another potential redox partner of SaDsbA could be SA2198. Since no homologue of SA2198 has been found outside the Staphylococcus genus, it is currently not feasible to estimate its function. The findings that dsbA and SA2198 are co-transcribed, the similar genetic organisation in S. epidermidis, and that SA2198 is predicted to be localised in the same cellular compartment as SaDsbA, support the possibility that both proteins are functionally linked. However, the lack of cysteine residues in SA2198, which are essential for DsbB activity (Guilhot et al. 1995) , and the observation that plasmid pAD2, containing SA2198 -dsbA, was not more efficient at restoring the motility of the E. coli mutants than plasmid pAD11, encoding only SaDsbA, seemed to exclude a DsbB-like action of SA2198 on SaDsbA.
In conclusion, despite its low sequence similarity to E. coli DsbA, and being a membrane anchored protein, the staphylococcal DsbA can functionally replace E. coli DsbA. SaDsbA is thus the first S. aureus protein shown to have the potential for extracellular disulfide bond formation. The finding that S. aureus, as well as some other bacteria, encode a DsbA but lack a DsbB homologue, leads us to postulate the existence of an alternative disulfide formation pathway distinct from the classical DsbA-DsbB electron cascade. The exact function of SaDsbA in staphylococci, and its importance for virulence of the human pathogens S. aureus and S. epidermidis remains to be elucidated.
